Vanguard Group Inc Gossamer Bio, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
109Shares Held
167MCall Options Held
450KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$20.8 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$15.3 Million0.65% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$10.6 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.26 Million4.79% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.43MShares$7.4 Million0.0% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $108M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...